Pediatrics. 2024 Sep 26:e2024065963. doi: 10.1542/peds.2024-065963. Online ahead of print.
ABSTRACT
OBJECTIVE: To provide contemporary data on infants inborn at 22 to 25 weeks’ gestation and receiving care at level 3 and 4 neonatal intensive care units in the United States.
METHODS: Vermont Oxford Network members submitted data on infants born at 22 to 25 weeks’ gestation at a hospital with a level 3 or 4 NICU from 2020 to 2022. The primary outcome was survival to hospital discharge. Secondary outcomes included survival without severe complications, length of stay, and technology dependence.
RESULTS: Overall, 22 953 infants at 636 US hospitals were included. Postnatal life support increased from 68.0% at 22 weeks to 99.8% at 25 weeks. The proportion of infants born at 22 weeks receiving postnatal life support increased from 61.6% in 2020 to 73.7% in 2022. For all infants, survival ranged from 24.9% at 22 weeks to 82.0% at 25 weeks. Among infants receiving postnatal life support, survival ranged from 35.4% at 22 weeks to 82.0% at 25 weeks. Survival without severe complications ranged from 6.3% at 22 weeks to 43.2% at 25 weeks. Median length of stay ranged from 160 days at 22 weeks to 110 days at 25 weeks. Among survivors, infants born at 22 weeks had higher rates of technology dependence at discharge home than infants born at later gestational ages.
CONCLUSIONS: Survival ranged from 24.9% at 22 weeks to 82.1% at 25 weeks, with low proportions of infants surviving without complications, prolonged lengths of hospital stay, and frequent technology dependence at all gestational ages.
PMID:39323403 | DOI:10.1542/peds.2024-065963
